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DOI 10.1016/j.ccr.2011.05.008SUMMARYTumors and associated stroma manifest mechanical properties that promote cancer. Mechanosensation of
tissue stiffness activates the Rho/ROCK pathway to increase actomyosin-mediated cellular tension to
re-establish force equilibrium. To determine how actomyosin tension affects tissue homeostasis and tumor
development, we expressed conditionally active ROCK2 inmouse skin. ROCKactivation elevated tissue stiff-
ness via increased collagen. b-catenin, a key element of mechanotranscription pathways, was stabilized by
ROCK activation leading to nuclear accumulation, transcriptional activation, and consequent hyperprolifer-
ation and skin thickening. Inhibiting actomyosin contractility by blocking LIMK or myosin ATPase attenuated
these responses, as did FAK inhibition. Tumor number, growth, and progression were increased by ROCK
activation, while ROCK blockade was inhibitory, implicating actomyosin-mediated cellular tension and
consequent collagen deposition as significant tumor promoters.INTRODUCTION
Tumors grow in complex environments in which external factors,
such as tissue rheology (Butcher et al., 2009), influence growth,
and progression. Despite the association of tissue stiffness with
cancer being sowell established that palpation and elastography
arediagnostic procedures for some tumors, themechanisms that
translate mechanosensation of external conditions to the induc-
tion of tumor-promoting responses remain poorly understood.
RhoGTPases act as network hubs that transduce signals from
the extracellular environment to proteins that mediate biologicalSignificance
Biophysical studies have revealed that extracellular forces
activation to balance internal and external forces. The results
actomyosin-mediated cellular contractile force drives tissue
b-catenin-mediated hyperproliferation, which increase tumo
ROCK-mediated cellular tension promotes cancer growth and
mediate frequently activated in human cancer by direct actions
by growth factor receptors activated bymutation or increased l
between cell and tissue level forces.
776 Cancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc.responses (Parsons et al., 2010). ROCK1 and ROCK2 are essen-
tial for RhoA and RhoC-initiated actomyosin contractility through
phosphorylation of substrates including LIM kinases (LIMK),
myosin regulatory light chains (MLC2), and the myosin-binding
subunit of the MLC phosphatase (MYPT), which facilitates cell
movement and contributes to cancer metastasis (Olson and
Sahai, 2009). Rho activation was first found after growth factor
receptor stimulation (Ridley and Hall, 1992), but Rho proteins
respond to additional inputs, including external force, to affect
cytoskeletal structure and function (Parsons et al., 2010).
External tensile force results in compensatory Rho/ROCKevoke mechanoreciprocal cellular tension via Rho/ROCK
of this study reveal that ROCK activation and consequent
stiffness via elevated collagen deposition and promotes
r burden and progression. These findings indicate that
progression, and illustrate how a key GTPase signaling inter-
of regulatory proteins, by upstream signaling oncogenes or
igand levels can promote cancer bymodulating the interplay
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librium (Wozniak et al., 2003; Zhao et al., 2007). At the same time,
internal cellular tension remains in equilibrium with the external
microenvironment through the reorganization, modification,
and/or synthesis of extracellular matrix (ECM) proteins (Chiquet
et al., 2009;Wu et al., 2007). In some pathological contexts, force
equilibration may not be achieved, resulting in a mechanical au-
tocrine loop that drives rheological changes and consequent
tissue stiffness.
Skin is a mechanically responsive tissue (Silver et al., 2003),
which forms a barrier that protects against damaging environ-
mental stresses. Net tension in the skin is a balance between
external collagen fibrils and internal actomyosin cellular tension
(Silver et al., 2003). To maintain barrier integrity, cells are con-
stantly renewed in a tightly controlled process termed epidermal
homeostasis (Blanpain and Fuchs, 2009). Squamous cell carci-
noma (SCC) develops in keratinocytes that have differentiated
and moved from the basal layer, and is the second most
common skin cancer (Xie, 2008). Rho and ROCK signaling are
associated with SCC (Jiang et al., 2010; Lefort et al., 2007;
Wang et al., 2009), although details of how Rho/ROCK may
promote SCC are lacking.
In this current study, we investigated how actomyosin cellular
tension influences tissue rheology, epidermal homeostasis, and
tumor growth and progression.
RESULTS
ROCK Activation Increases Tissue Stiffness
To investigate how cellular tension affects tissue homeostasis
and cancer, we created K14-ROCK:ER mice (Samuel et al.,
2009a) that express a chimeric protein (ROCK:ER) consisting of
the human ROCK2 kinase domain fused to mutant 17b-estra-
diol-insensitive estrogen receptor (ER) hormone binding domain
(HBD) (Littlewood et al., 1995) and enhanced green fluorescent
protein (EGFP) under the control of theK14promoter (seeFigures
S1A and S1B available online). Upon HBD binding of tamoxifen
or 4-hydroxytamoxifen (4HT), ROCK:ER is activated and phos-
phorylates physiological substrates leading to actomyosin-
mediated contractility (Samuel et al., 2009a). K14-ROCK:ER and
a control kinase-dead (KD) version (K14-KD:ER) were each
targeted to theHprt locus, leading to expression15%of endog-
enous ROCK2 (Samuel et al., 2009a). Consistent with previous
results (Samuel et al., 2009a), 4HT treatment of K14-ROCK:ER
mouse skin increased Mlc2 phosphorylation, but not in K14-
KD:ER or Wild-type (WT) control mice (Figure 1A). Thr696 phos-
phorylation of themyosin binding subunit of theMlc phosphatase
(pMypt1), which inhibits Mlc dephosphorylation (Feng et al.,
1999), was also increased by 4HT specifically in K14-ROCK:ER
mouse skin (Figure 1A).
To determine how ROCK activation and consequent cellular
tension affected tissue rheology, K14-ROCK:ER and WT skin
dorsal skin was given five daily 4HT treatments, then subjected
to rheological analysis by atomic force microscopy (AFM).
Compared to WT skin, ROCK activated skin showed an AFM
force map skewed toward high kPa values and a significant
increase in Young’s modulus, demonstrating increased tissue
stiffness (Figures 1B and 1C). When viewed through orthogonal
polarizing filters, ROCK activated skin also had increasedpicrosirius red fluorescence, indicating increased collagen fiber
diameters (Figures 1B and 1C). Accordingly, second harmonic
generation (SHG) analysis of 4HT-treated K14-ROCK:ER skin
showed increased collagen density and expanded distribution
from the epidermal surface to greater depths compared to WT
(Figures 1D and 1E;Movie S1,Movie S2, andMovie S3), confirm-
ing previous reports of correlations between optical and
mechanical properties of collagen in vivo (Raub et al., 2008,
2010). These results show that ROCK-induced actomyosin
cellular tension is associated with increased collagen fiber diam-
eter and elevated collagen deposition over a broader distribu-
tion. Therefore, internal cellular tension drives significant
tissue-level compensatory responses.
ROCK Activation Drives Epidermal Proliferation
and Skin Thickening
Within 5 days of daily 4HT treatment, ROCK activated skin was
significantly thicker than K14-KD:ER andWT skin (Figure 2A; Fig-
ure S2A), associated with interfollicular epidermal expansion by
several cell layers. ROCK-induced epidermal thickening was
associated with a significant doubling in BrdU-positive prolifer-
ating basal keratinocytes relative to control K14-KD:ER or WT
mice (Figure 2B; Figure S2B). K14-ROCK:ER keratinocytes
cultured in 4HT grew in soft agar, yielding 2.5-fold as many
anchorage-independent colonies as K14-KD:ER keratinocytes
(Figure 2C). Y27632 treatment abolished this effect, showing
ROCK dependence of the increased anchorage-independent
growth.
ROCK-induced skin thickening was associated with expan-
sion of the suprabasal interfollicular epidermal cell layer express-
ing cytokeratin 1 (K1) and ectopic expression of the follicular
cytokeratin 6 (K6) by immunofluorescence and FACS analyses
(Figure 2D; Figures S2B and S2C). K14-KD:ER and WT control
mice had no skin thickening and retained normal K1 and K6
expression following 4HT treatment (Figure 2D; Figure S2D).
Inhibition of lysyl oxidase (Lox) with b-aminopropionitrile
(BAPN) to reduce collagen fibril crosslinking in rigid matrices
(Levental et al., 2009) reversed K6 induction (Figure 2D). K6
expression, which is commonly observed in SCC (Haass et al.,
2006; Khayyata et al., 2009), has been associated with either
epidermal hyperplasia or inflammation (Kopan and Fuchs,
1989; Stoler et al., 1988; Weiss et al., 1984). However, inflamma-
tory infiltrate as observed in DMBA/TPA papillomas was not
evident in ROCK activated skin (Figure S2E). The observations
that ROCK activation caused skin thickening, increased prolifer-
ation, K6 expression and anchorage independent growth indi-
cate that sustained actomyosin-mediated cellular tension has
a proproliferative role within the epidermis.
ROCK Activates b-Catenin and Elevates Transcriptional
Target Expression
b-catenin has important roles in epidermal homeostasis and
tumorigenesis, regulating progenitor cell proliferation through
Tcf/Lef target gene transcription (Lo Celso et al., 2004; Malanchi
et al., 2008; Nguyen et al., 2009; Zhu and Watt, 1999). b-catenin
is also a central element in transcription pathways responsive to
mechanical stimulation (Arnsdorf et al., 2009; Sen et al., 2009),
suggesting that b-catenin might mediate responses to elevated
collagen and tissue stiffness. ROCK activation within theCancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc. 777
Figure 1. ROCK Activation Increases Epidermal Tissue Stiffness and the Density and Depth of Collagen Deposition within the Skin
(A) Western blot shows Mlc2 Ser19 phosphorylation in 4HT-treated WT, KD:ER and ROCK:ER keratinocytes. Immunohistochemical analyses show pMypt1
staining in 4HT or vehicle-treated WT, KD:ER and ROCK:ER skin.
(B) AFM Force maps of 4HT-treated WT and ROCK:ER skin areas enclosed by yellow square as well as picrosirius red staining viewed through parallel or
orthogonally polarizing filters.
(C) Quantification of Young’s elastic Modulus and % area threshold of collagen in 4HT-treated WT and ROCK:ER skin, expressed as mean ± SD.
(D) Maximum projections along three axes of SHG collagen signal from representative 5003 5003 200 mm volumes of 4HT-treated WT and ROCK:ER skin. Red
double headed arrows show relative thicknesses of collagen layer in 4HT-treated WT and ROCK:ER skin.-
(E) Graphs of collagen coverage values derived from SHG signal by depth (line graph) and at peak value (histogram inset), measured over three tissue volumes
each from three mice per cohort. Results are mean ± SEM.
Scale bars, 100 mm.
See also Figure S1 and Movie S1, Movie S2, and Movie S3.
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Figure 2. ROCK Activation within Murine Skin Causes Epidermal Hyperplasia
(A) Hematoxylin and eosin (H&E)-stained skin sections derived from 4HT-treated WT, KD:ER and ROCK:ER mice. Change in ROCK:ER interfollicular epidermis
thickness (arrows) compared to WT and KD:ER skin following five daily topical 4HT treatments is shown in histogram. Measurements were made over five fields
with three measurements taken per field. Scale bars, 20 mm.
(B) BrdU incorporation in skin sections derived from 4HT-treated WT, KD:ER and ROCK:ER mice. Histogram shows number of BrdU-labeled cells per mm
basement membrane (BM) following 4HT treatment. Scale bars, 50 mm.
(C) Histogram shows fold change in number of colonies formed in soft agar by 4HT-treated ROCK:ER keratinocytes relative to KD:ER keratinocytes.
Representative fields of colonies are shown. Scale bars, 100 mm.
(D) K1, K6 and K14 expression in skin sections derived from 4HT-treatedWT, KD:ER and ROCK:ER mice, without or with BAPN treatment to inhibit lysyl oxidase.
Scale bars, 100 mm. Histogram shows percentage K6 positive cells within epidermis derived from 4HT-treated WT, KD:ER and ROCK:ER mice as measured by
FACS (see Figure S2C for profiles).
See also Figure S2. Histograms show mean ± SD.
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Figure 3. ROCK Activation in the Murine
Epidermis Is Associated with Tcf/Lef Target
Gene Activation
(A) Expression of CD44 variants v3 and v3-v10 in
4HT-treated KD:ER and ROCK:ER skin by immu-
nofluorescence. Scale bars indicate 100 mm.
Histogram shows CD44v3 mRNA expression
within WT, KD:ER, and ROCK:ER epidermis.
(B) Cyclin D1 expression in 4HT-treated ROCK:ER
(arrow) and KD:ER skin. Histogram shows cyclin
D1 mRNA expression within WT, KD:ER and
ROCK:ER epidermis.
(C) Ectopic expression (yellow arrows) of Lgr5
promoter-driven EGFP:Cre within interfollicular
epidermis in 4HT-treated KD:ER and ROCK:ER
skin. Boxed areas are enlarged in insets. Histo-
gram shows Lgr5 mRNA expression within WT,
KD:ER, and ROCK:ER epidermis.
(D) Fresh-frozen skin from 4HT-treated TOPGAL
mice on KD:ER and ROCK:ER backgrounds in
which b-Galactosidase activity was visualized
using fluorescein di-galactoside. A red filter has
been added to monochromatic channel to aid
visualization.
(E) Tcf/Lef transcriptional activity in ex vivo
cultured KD:ER and ROCK:ER keratinocytes
assayed using TOPFlash reporter assay. GSK3b
inhibitor BIO was used as positive control.
See also Figure S3. Histograms show mean ± SD.
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Tcf/Lef target genes CD44 (Wielenga et al., 1999), cyclin D1
(Shtutman et al., 1999; Tetsu and McCormick, 1999) and Lgr5
(Jaks et al., 2008) at mRNA and protein levels (Figures 3A–3C)
relative to K14-KD:ER and WT epidermis. CD44 and cyclin D1
mRNA were also upregulated in primary cultured keratinocytes
by ROCK activation (Figure S3).
To confirm Tcf/Lef transcriptional activation, K14-ROCK:ER
and K14-KD:ER mice were crossed with TOPGAL reporter
mice, which express b-galactosidase under the control of an
engineered TOP promoter containing three tandem Tcf/Lef
consensus binding sites, (DasGupta and Fuchs, 1999). TOPGAL;780 Cancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc.K14-ROCK:ER mice expressed b-galac-
tosidase throughout the interfollicular
epidermis upon 4HT treatment, unlike
TOPGAL; K14-KD:ER mice (Figure 3D).
Luciferase-based Tcf/Lef (TOPFlash)
assays of cultured primary keratinocytes
also showed significant 4HT-induced Tcf/
Lef transcriptional activity in ROCK:ER
expressing cells, comparable to KD:ER
or ROCK:ER cells treated with GSK3b in-
hibitor 6-bromoindirubin-39-oxime (BIO)
(Meijer et al., 2004; Figure 3E). These
results show that ROCK activation in-
creased b-catenin transcriptional activity
and target gene transcription, which
could drive interfollicular epidermal cell
proliferation.
Immunofluorescence of ROCK-acti-
vated epidermis revealed re-distributionof b-catenin (red fluorescence and red trace) from membrane
to cytoplasm (red arrowheads) and nucleus (blue arrowheads),
compared to identically treated control K14-KD:ER mice
(Figures 4A and 4B). In contrast, E-cadherin (green fluorescence
and green trace), which associates with b-catenin in adherens
junctions remained at the cell membrane (Figures 4A and 4B).
An image processing macro (see Supplemental Experimental
Procedures) developed to quantify nuclear and cytoplasmic
localization of b-catenin immunofluorescence showed 2-fold
increase in nuclear b-catenin upon ROCK activation and 5-fold
elevation in total b-catenin relative to K14-KD:ER epidermis,
consistent with b-catenin western blots of epidermal lysates
Figure 4. b-Catenin Is Stabilized and Relocalized upon ROCK Induction within the Interfollicular Epidermis
(A) Confocal slice showing b-catenin (red) and E-cadherin (green) distribution in 4HT-treated KD:ER and ROCK:ER skin.
(B) Pixel intensity of red (b-catenin), green (E-cadherin), and blue (DAPI) fluorescencemeasured along red arrows in Figure 4A to assess colocalization.Membrane
and nuclear regions are denoted. Red fluorescence is observed within cytoplasm (red arrowheads) and nucleus (blue arrowheads) in 4HT-treated ROCK:ER but
not KD:ER skin.
(C) Pixel intensity of nuclear or total b-catenin staining in 4HT-treated KD:ER and ROCK:ER skin sections shown as quartiles. Measurements were carried out on
five fields each of sections derived from three mice per genotype. Western analysis shows b-catenin protein level in pooled epidermal lysates from 4HT-treated
KD:ER and ROCK:ER mice (three mice per genotype).
(D) FACS of b-catenin staining versus forward scatter of epidermal cells derived from WT, KD:ER and ROCK:ER skin. Histogram shows percentage b-catenin-
positive cells in each sample, expressed as mean ± SD.
(E) Unphosphorylated (Ser37/Thr41)-b-catenin (red) and phosphorylated (Ser9) GSK3b (green) distribution in 4HT-treated KD:ER and ROCK:ER skin, either
without or with BAPN treatment to inhibit lysyl oxidase.
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in ROCK-activated epidermis by FACS analysis of dissociated
cells (Figure 4D). Immunofluorescence of ROCK-activated
epidermis using an antibody against activated b-catenin
(dephosphorylated at Ser37 and Thr41) (van Noort et al., 2002)
revealed that nuclear localized b-catenin is the activated form
(Figure 4E), which was associated with increased phosphoryla-
tion of GSK3b on Ser9 that blocks phosphorylation of substrates
such as b-catenin (Dajani et al., 2001). BAPN treatment to inhibit
Lox activity and collagen crosslinking reversed both the nuclear
accumulation of active b-catenin and GSK3b phosphorylation
(Figure 4E). These results indicate that the epidermal hyperprolif-
eration in ROCK-activated epidermis is associated with Tcf/Lef
transcriptional activity brought about by stabilization and activa-
tion of b-catenin.
b-Catenin Deletion Abolishes ROCK-Induced Epidermal
Hyperproliferation
To determine whether b-catenin mediates ROCK-induced hy-
perproliferation, we crossed K14-ROCK:ER and K14-KD:ER
mice onto a background homozygous for a conditional floxed
b-catenin allele (Ctnnb1tm2Kem) (Brault et al., 2001) and K14-
driven Cre recombinase/ER fusion protein expression (K14-
Cre:ER) (Vasioukhin et al., 1999). K14-ROCK:ER; b-cateninFl/Fl;
K14-Cre:ER compound mutant mice treated for 5 days with
4HT exhibited loss of b-catenin within the interfollicular epi-
dermis (Figure 5A; Figure S4A), which did not affect ROCK
activation or LIMK activity, as shown by Mypt and cofilin phos-
phorylation respectively (Figure S4B). b-catenin deletion blocked
ROCK-induction of CD44v3-v10 or cyclin D1 (Figure 5B; Fig-
ure S4C). In the absence of b-catenin, ROCK activation did not
induce epidermal hyperproliferation as indicated by reduced
Ki67 immunoreactivity or skin thickening (Figure 5C; Figure S4D).
Indeed, b-catenin loss completely abolished ROCK-mediated
skin thickening (Figure 5D) and normalized Ki67 labeling (Fig-
ure 5E), but did not affect ROCK-induced collagen deposition
(Figure 5F), indicating that elevated collagen is not a conse-
quence of b-catenin activation. b-catenin loss had no effect on
epidermal homeostasis in control K14-KD:ER mice (Figure S4E).
Consistent with b-catenin being a driver of epidermal prolifera-
tion, K14-Cre:ER, Ctnnb1tm1Mmt/+ mice expressing a 4HT-induc-
ible version of constitutively active b-catenin (Harada et al., 1999)
exhibited 5-fold interfollicular epidermal thickening associated
with increased b-catenin (Figure 5G). These results indicate that
ROCK-induced interfollicular epidermal hyperproliferation is
b-catenin dependent, associated with increased b-catenin tran-
scriptional activity and expression of b-catenin regulated tran-
scriptional targets, placing ROCK activation and actomyosin-
mediated cellular tension in a pathway leading to b-catenin
activation.
Actomyosin Contractility Is Required for ROCK-Induced
Epidermal Proliferation
LIMK1 and LIMK2 are phosphorylated and activated by ROCK,
and, in turn, phosphorylate and inactivate the F-actin severing
cofilin proteins (Scott and Olson, 2007). To determine whether
inhibiting mediators of actomyosin contractility would block
ROCK-induced epidermal hyperproliferation, a selective and
nontoxic LIMK inhibitor (LIMKi; compound 3 in (Ross-Macdonald782 Cancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc.et al., 2008)), was applied in combination with 4HT. Staining with
phosphocofilin specific antibody (Figure S5A) revealed that
a single LIMKi treatment abolished cofilin phosphorylation (Fig-
ure S5B). LIMKi application with 4HT for 5 days blocked skin
thickening and ectopic interfollicular K6 in K14-ROCK:ER mice
(Figure 6A white arrows, Figure 6B; Figure S5C), accompanied
by absence of cofilin phosphorylation (Figure 6A; Figure S5C)
and reduced b-catenin levels (Figure 6A, yellow arrow). Similarly,
inhibition of myosin ATPase activity to block actomyosin
contraction with daily Blebbistatin (Straight et al., 2003) applica-
tion eliminated skin thickening, ectopic interfollicular K6 expres-
sion and reduced b-catenin levels (Figures 6A and 6B). Lox
inhibition with BAPN to reduce collagen crosslinking also signif-
icantly reduced skin thickening (Figure 6B). LIMKi and Blebbista-
tin also reduced ROCK-induced BrdU incorporation in 4HT-
treated K14-ROCK:ER skin to a level comparable to untreated
K14-ROCK:ER skin (Figure 6C), confirming that ROCK-induced
hyperproliferation was reversed by inhibition of actomyosin
contractility. In primary cultured keratinocytes, Y27632 or LIMKi
reduced ROCK-induced BrdU incorporation to levels observed
in untreated cells or 4HT-treated control K14-KD:ER keratino-
cytes (Figure S5D). ROCK-induced collagen deposition also
was significantly reduced by LIMKi or Blebbistatin (Figure 6D).
These observations indicate that interfollicular epidermal hyper-
proliferation, b-catenin accumulation, and collagen deposition
following ROCK activation are dependent upon sustained
cellular tension mediated by actomyosin contractility.
b-Catenin Stabilization Induced by Integrin-Responsive
Signaling Pathway
Collagen is a major extracellular matrix protein that influences
cellular behaviors by promoting integrin clustering and activating
downstream signaling (Egeblad et al., 2010), with FAK activation
being an early response (Zhao and Guan, 2009). FAK autophos-
phorylation at Tyr397was elevated in 4HT-treatedROCK:ER skin
relative to control KD:ER orWT skin (Figure 7A), while application
of the selective FAK inhibitor PF-562271 (Roberts et al., 2008)
blocked FAK autophosphorylation (Figure 7A). The PI3K/Akt
axis has been shown to be important in FAK-mediated signaling
downstream of collagen-activated integrins (Tian et al., 2002).
Akt phosphorylation on an activating Ser473 position was
elevated in ROCK-activated skin and reduced by topical applica-
tion of FAK inhibitor PF-562271 (Figure 7B). Akt phosphorylates
GSK3b on Ser9, thereby creating a competitive pseudosubstrate
that blocks substrate phosphorylation (Dajani et al., 2001). ROCK
activation increased GSK3b Ser9 phosphorylation relative to
control 4HT-treatedWT or KD:ER skin (Figure 7C), accompanied
by decreased b-catenin phosphorylation on GSK3b sites Ser37
andThr41 (Figure 7C). Both increased inhibitoryGSK3b inhibitory
Ser9phosphorylation and decreased b-catenin Ser37 and Thr41
phosphorylation were reversed by FAK inhibitor PF562271 (Fig-
ure 7C). In support of a FAK > PI3K/AKT >GSK3b pathway being
responsible for b-catenin regulation, the increased levels of
b-catenin and skin thickening in ROCK activated skin were
blocked by FAK inhibitor PF562271 (Figures 7D and 7E).
ROCK Promotes Papillomagenesis
To test the effect of cellular tension on tumor growth and
progression, we examined how ROCK activation influenced
Figure 5. ROCK-Induced Epidermal Hyperproliferation is b-Catenin Dependent
Vehicle or 4HT-treated b-cateninFl/Fl; K14-Cre:ER mice expressing KD:ER or ROCK:ER as indicated were stained or scored as indicated.
(A) b-catenin.
(B) b-catenin target genes CD44 (top panels) and cyclin D1 (bottom panels).
(C) Ki-67 (top panels) and H&E (bottom panels). Skin thickness differences are indicated by white arrow pairs in H&E panels.
(D) Skin thickness.
(E) Ki67 positive cells per mm basement membrane.
(F) Collagen area coverage by SHG, shown as quartiles.
(G) K14-Cre:ER, Ctnnb1tm1Mmt/+ mice were treated as indicated with vehicle or 4HT to activate b-catenin. Panels show b-catenin staining and skin thickness
(arrows); histogram indicates fold change in skin thickness.
Scale bars, 100 mm.
See also Figure S4. Histograms show mean ± SD.
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Figure 6. ROCK-Induced Epidermal Hyperproliferation Is Dependent on Actomyosin Contractility
(A) Skin sections fromROCK:ERmice treated with vehicle or 4HT, 4HT+LIMKi or 4HT+Blebbistatin, stained with H&E or for K6, K14, b-catenin, or pCfl. Scale bars
indicate 100 mm.
(B) Fold change in ROCK:ER skin thickness relative to KD:ER skin following 4HT treatment in absence or presence of LIMKi, Blebbistatin, or BAPN.
(C) BrdU incorporation scored as positive cells per mm BM from untreated, 4HT-treated 4HT+LIMKi or 4HT+Blebbistatin-treated ROCK:ER skin.
(D) Collagen area coverage in ROCK:ER skin following 4HT treatment in absence or presence of LIMKi or Blebbistatin, shown as quartiles.
See also Figure S5. Histograms show mean ± SD.
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Syngeneic papillomas are induced in FVB/N mice by one appli-
cation of the mutagen dimethylbenz[a]anthracene (DMBA) fol-
lowed by repeated applications of 12-O-tetradecanoylphorbol-
13-acetate (TPA) (Hennings et al., 1993). Papillomas arise and
reproducibly convert at low frequency to invasive carcinomas
by a mechanism involving H-Ras mutations and MAP-kinase784 Cancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc.activation (Balmain et al., 1984; Quintanilla et al., 1986). Tumors
produced by this procedure model human SCC and have been
used to determine the dependence on genes such as b-catenin
(Malanchi et al., 2008).
K14-ROCK:ER or K14-KD:ER mouse cohorts backcrossed at
least ten generations onto the FVB/N background were treated
twice weekly with vehicle or 4HT in addition to DMBA/TPA for
Figure 7. FAK, Akt, and GSK3b Phosphorylation Increased in ROCK-Activated Skin
WT, KD:ER and ROCK:ER skin treated with 4HT alone or 4HT plus FAK inhibitor PF-562271 stained as indicated.
(A) K14 (red) and FAK pTyr397 (green).
(B) K14 (red) and Akt pSer473 (green).
(C) GSK3b pSer9 (green) and unphosphorylated b-catenin Ser37/Thr41 (red).
(D) Total b-catenin (green).
(E) Fold change in ROCK:ER skin thickness relative to KD:ER skin following 4HT treatment in absence or presence of FAK inhibitor PF-562271, expressed as
mean ± SD.
Scale bars, 100 mm
See also Figure S6.
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ROCK Regulation of Epidermal Fatea total of 15 weeks (Figure 8A), at which point carcinomas were
observed and the experiment halted. Significantly increased
papilloma numbers were observed in 4HT-treated K14-
ROCK:ER mice compared to 4HT or vehicle-treated K14-
KD:ER mice or vehicle-treated K14-ROCK:ER mice (Figure 8B;
Figure S6A). A shift toward larger papillomas (Figure 8C) and
increased papilloma incidence (Figure 8B) resulted in a signifi-
cantly greater total papilloma burden (a function of papilloma
volume and number) in 4HT-treated K14-ROCK:ERmice relative
to vehicle-treated control and to both K14-KD:ER treatment
groups (Figure 8D). Only the ROCK-activated cohort had papil-
loma to carcinomas conversion within 15 weeks (Figure 8D).
SHG analysis of epidermal collagen revealed significantly higher
levels in the keratinocyte layer associated with resident papil-
lomas (Figure 8E). Total and nuclear b-catenin were significantly
increased in 4HT-treated K14-ROCK:ER papillomas compared
with 4HT-treated K14-KDK:ER papillomas, consistent with the
increased tumor growth (Figure 8F; Figure S6B). These results
show that sustained ROCK activation is sufficient to elevate
collagen, activate b-catenin and increase papilloma incidence,
growth, and progression to carcinoma.
The selective ROCK inhibitor Y27632 (Uehata et al., 1997) was
used to reduce Rock signaling during DMBA/TPA-induced pap-
illomagenesis. Y27632 treatment of DMBA/TPA-treated FVB/N
mice markedly reduced pMypt levels within hyperproliferative
skin and papillomas (Figure S6C), confirming tissue penetration
and Rock inhibition. Pure FVB/N cohorts treated with Y27632
(Figure 8G) twice weekly during the DMBA/TPA procedure
developed significantly fewer (Figure 8H; Figure S6C) and
smaller papillomas (Figure 8I) than control vehicle-treated
mice, resulting in significantly reduced tumor burden (Figure 8J).
Papilloma to carcinoma conversion rate was 6.5% in the DMBA/
TPA-treated cohort, but only 1.5% in the cohort coadministered
Y27632 within the 20 week treatment course (Figure 8J).
Collagen levels were significantly reduced in the keratinocyte
layer associated with resident papillomas as determined by
SHG (Figure 8K). Y27632-treated papillomas also exhibited sig-
nificantly lower cyclin D1 and Ki67 histoscores compared withFigure 8. ROCK Activation Accelerates Papilloma Growth and Progres
(A) Timeline of 15 week chemical carcinogenesis and ROCK activation in cohort
orange arrow , DMBA; black arrows, TPA; green arrows, 4HT or vehicle. Papilloma
(B) Box and whisker plot of DMBA/TPA-induced papillomas per mouse in ROCK
(C) Pie charts of papilloma size distribution at completion of 15 week treatment
Carcinomas are not included.
(D) Histogram of DMBA/TPA papilloma burden and carcinoma conversion rate in
(E) Collagen area coverage measured by SHG in 4HT-treated KD:ER or ROCK:E
(F) Pixel intensity of nuclear or total b-catenin staining in 4HT-treated KD:ER or RO
per condition.
(G) Timeline of 20 week chemical carcinogenesis and ROCK inhibition in cohorts o
gray arrows, Y27632 or vehicle. Papilloma to carcinoma conversion events are d
(H) Box and whisker plot of DMBA/TPA-induced papillomas per mouse in vehicl
(I) Pie charts of papilloma size distribution at completion of 20week treatment peri
(J) Histogram of DMBA/TPA papilloma burden and carcinoma conversion rate in
(K) Collagen area coverage measured by SHG in DMBA/TPA-treated skin along
(L) Pixel intensity of nuclear or total b-catenin staining in vehicle or Y27632-treate
condition.
(M) Results of positive pixel analyses of ROCK expression and MYPT phosphory
(N) Correlation curve of pMYPT and ROCK positive pixel analyses. The 95%confid
using Chi-square test. A Pearson product-moment correlation coefficient (r) of 0
See also Table S1. Histograms show mean ± SD; box and whisker plots show qvehicle-treated papillomas (Figure S6D). Total as well as nuclear
b-catenin was significantly reduced in Y27632-treated papil-
lomas, consistent with the reduced tumor growth (Figure 8L; Fig-
ure S6E). These results show that Rock inhibition lowered
epidermal collagen, reduced papillomagenesis, and delayed
tumor growth and progression by reducing proliferation, indi-
cating that actomyosin-mediated cellular tension makes crucial
contributions to tumor promotion.
Human Skin Tumors Exhibit Elevated ROCK Expression
and Activity
To determine whether ROCK signaling was altered in human skin
cancers, immunohistochemical analysis of a tissue microarray
derived from 40 cases of human squamous skin carcinomas
was carried out with a pan-specific ROCK1/2 antibody (Fig-
ure S6F) and a phosphospecific antibody for the ROCK substrate
MYPT as an indicator of ROCK activation. Most skin tumors
analyzed (90%) expressed high ROCK levels relative to pheno-
typically normal skin (Table S1 and Figure S6G). Positive pixel
analysis of SCC samples revealed statistically significant
increases in ROCK and pMYPT relative to normal skin samples
(Figure 8M), and MYPT phosphorylation correlated significantly
with ROCK expression (Figure 8N). These results show that
ROCK overexpression correlates with ROCK activation and is
a common occurrence in human SCC, suggesting that ROCK
activation drives cellular tension to promote human skin cancer.
However, pMYPT staining indirectly correlates with MLC2 phos-
phorylation and actomyosin contractility and as a consequence,
inferences should be treated with some caution.
DISCUSSION
Collagen, a major component of the extracellular matrix, may be
increased in density as well as in posttranslational modifications
that alter the structure and organization of collagen fibers,
contributing to variations in tissue stiffness (Egeblad et al.,
2010). Cells grown in vitro on stiff collagen matrices have been
shown to activate Rho and ROCK signaling leading to increasedsion
s of six mice of ROCK:ER and KD:ER genotypes. Treatments were as follows:
to carcinoma conversions in individual ROCK:ERmice denoted by red arrows.
:ER and KD:ER mice treated with vehicle or 4HT as indicated.
period in ROCK:ER and KD:ER mice treated with vehicle or 4HT as indicated.
ROCK:ER and KD:ER mice treated with vehicle or 4HT as indicated.
R skin.
CK:ER DMBA/TPA papillomas. Measurements were carried out on seven fields
f 6WT FVB/Nmice. Treatments were: orange arrow, DMBA; black arrows, TPA;
enoted by red arrows.
e or Y27632-treated WT FVB/N mice.
od in Y27632- or vehicle-treatedWT FVB/Nmice. Carcinomas are not included.
vehicle or Y27632-treated WT FVB/N mice.
with vehicle or Y27632.
d DMBA/TPA papillomas. Measurements were carried out on seven fields per
lation in a sample of 40 human epidermal squamous cell carcinomas.
ence interval is denoted by dotted lines. Statistical significance was calculated
.7 confirms a large correlation between ROCK and pMYPT positive pixels.
uartiles.
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ROCK Regulation of Epidermal Fateactomyosin contractility, which generates counterbalancing
cellular tension in an attempt to balance internal and external
forces (Paszek et al., 2005; Wozniak et al., 2003) in a process
dubbed ‘‘mechanoreciprocity’’ (Butcher et al., 2009). In addition
to this outside > inside signaling, there is evidence from cell-
based experiments that ROCK-mediated actomyosin contrac-
tility inside the cell may, conversely, reorganize extracellular
matrix structures or stimulate increased matrix protein synthesis
and secretion (Butcher et al., 2009; Discher et al., 2005; Huang
and Ingber, 2005; Provenzano et al., 2008; Wozniak et al., 2003).
We now show that the conditional activation of ROCK, the
principal driver of actomyosin contractility and cellular tension
via MYPT and MLC phosphorylation (Figure 1A) (Samuel et al.,
2009a), in murine epidermis results in significant modification
of the extracellular matrix through increased collagen deposition
leading to increased tissue stiffness. Accompanying the in-
creased tissue stiffness, activation of the mechanically respon-
sive b-catenin transcriptional coactivator promotes target gene
transcription and increased epidermal cell proliferation. These
results show that the development of cellular tension profoundly
affects the external microenvironment and influences tissue
homeostasis.
It has long been observed that tumor development is associ-
ated with increased tissue stiffness. In fact, cancers such as
mammary tumors are often detected by palpation or elastogra-
phy of the abnormally rigid tissue that surrounds them.
Increased stiffness of the cellular microenvironment contributes
significantly to tumor cell survival, proliferation, and progres-
sion (Egeblad et al., 2010). During the course of tumor growth
and progression, the tissue microenvironment undergoes
significant remodeling, which increases the mechanical forces
that cancer cells are subjected to evoking compensatory
responses via Rho and ROCK activation (Butcher et al.,
2009). Results from the present study also show that this rela-
tionship is reciprocal; increased ROCK-induced cellular tension
in vivo causes alterations in the extracellular matrix and
increased tissue stiffness. An important question is whether
the increased tissue stiffness induced by elevated cellular
tension is sufficient to promote tumor growth and progression.
The results from our study show that conditional ROCK activa-
tion and consequent increase in collagen deposition did indeed
increase tumor growth and progression, while ROCK inhibition
reduced these responses. Therefore, in addition to external
tissue-level forces modulating cellular responses, mechanical
alterations at the cellular-level can influence tissue mechano-
properties that promote cancer. It has generally been assumed
that the increased Rho and ROCK activity commonly observed
in cancer cells reflects a role in promoting invasion and metas-
tasis (Olson and Sahai, 2009). However, results from this study
indicate that altered expression and/or activity of actomyosin
regulators may promote tumor growth by influencing the tumor
microenvironment. Therefore, in addition to ROCK inhibition,
targeting proteins such as LIMK and myosin that work down-
stream of ROCK in the regulation of the actomyosin cytoskel-
eton may have antitumor therapeutic benefits by counteracting
the effects of cellular tension on the microenvironment. While
our studies clearly show a role of actomyosin contractility in
generating increased tissue stiffness via collagen deposition,
further work will be required to determine the relative contribu-788 Cancer Cell 19, 776–791, June 14, 2011 ª2011 Elsevier Inc.tions of tumor and tumor-associated cells such as stromal
fibroblasts.
Mechanical regulation of b-catenin has been well documented
in bone, a tissue often subjected to continuous and repeated
strain. Here, mechanical factors lead to b-catenin stabilization
and nuclear translocation, which is associated with the activa-
tion of a FAK > PI3K/Akt > GSK3b phosphorylation cascade
(Case and Rubin, 2010; Santos et al., 2010), in agreement with
the observations in mouse skin. Mechanical activation of the
Drosophila b-catenin homolog armadillo as a result of tissue-
level forces has also been reported (Desprat et al., 2008).
Increased b-catenin levels and concentration in cytoplasmic/
nuclear compartments have been reported in human cutaneous
SCC tumors (Malanchi et al., 2008; Papadavid et al., 2002),
consistent with the results in hyperproliferative murine skin (Fig-
ure 4). Interestingly, nuclear b-catenin levels are often elevated
at the host-tumor interface of invasive colorectal carcinomas
(Brabletz et al., 2005). These areas would be predicted sites of
elevated mechanoresistance leading to increased external
forces and consequently sites of high compensatory Rho/
ROCK activation. It would also follow that, in contrast to hard-
wired genetic or epigenetic alterations, these relatively acute
mechanical responses to external tension contribute to the
transdifferentiation potential of tumor cells and promote adapt-
ability of tumors to continuously evolving microenvironmental
factors, for instance, during the process of metastasis.EXPERIMENTAL PROCEDURES
Cell Culture
Primary keratinocytes were extracted from tail skin as described (McLean
et al., 2001). Cells were maintained at 37C/5% CO2/3% O2, in keratinocyte
growth medium (KBM-2; Clonetics) with epidermal growth factor (10 ng/ml),
insulin (5 mg/ml), hydrocortisone (0.5 mg/ml), bovine pituitary extract protein
(70 mg/ml), and 50 mM Ca2+ on collagen-1 coated dishes (Becton Dickinson).Clonogenic Survival Assays
Primary keratinocytes were seeded on dishes coated with 0.9% agarose/
DMEM (containing 10% FBS, L-glutamine and antibiotics) at 2 3 104 cells/
well in DMEM containing 0.45% agarose ± 1 mM 4HT and maintained at 37C/
10%CO2. DMEM± 1 mM4HTwas added to eachwell twiceweekly. Twoweeks
postseeding, colonies >80 mm in diameter were scored from five fields/well.Human Tissue Microarrays
HumanTMAswerepurchased fromProteinBiotechnologies,whichconfirms that
all tissuesampleswere collected under strict IRB-approvedguidelines/protocols
with informed consent. All collected human tissues were treated under strict
confidentiality and according to appropriate applicable laws that protect the
confidentialityofpersonal information.Nonamesoranyother identity information
were revealed during the development of tissue arrays, nor to end users, and as
a result are exempt from consideration by the Beatson Institute Committee on
Human Subjects in Medical Research due to being anonymized and nontrace-
able. CRUKguidelineswere followed in the handling andanalysis of thismaterial.
TMAscontaining tumor tissueand normal cores from40cases of squamous skin
cancer were baked for 2 hr at 60C prior to immunohistochemistry.Mice
K14-ROCK:ER mice were described previously (Samuel et al., 2009a).
TOPGAL [Tg(Fos-lacZ)34Efu/J] mice were from Jackson Labs. All procedures
were performed under appropriate licenses and according to the UK Home
Office guidelines.
Cancer Cell
ROCK Regulation of Epidermal FateIn Vivo Gene Induction and/or Activation and Enzyme Inhibition
4-Hydroxytamoxifen (4HT, Sigma, 1mg) in ethanol (100 ml) was applied
to shaved dorsal skin and repeated daily for up to 30 days. Inhibitors
(per mouse, Blebbistatin 23 mg; Y27632 25 mg; LIMKi 32 mg; PF-562271
160 mg; BAPN–760 mg) were applied topically once daily for 5 consecutive
days in appropriate vehicle.
Keratinocyte Extraction for Western and FACS
Epidermal tissue was separated as previously described (Nowak and Fuchs,
2009). Epidermal cells were lysed in 13RIPA buffer for western analysis, Trizol
(Invitrogen) for mRNA extraction or fixed in 4% paraformaldehyde for FACS
analysis using standard methods. All FACS analyses were carried out by first
gating K14 positive cells.
Chemical Carcinogenesis
Chemical carcinogenesis was carried out as described (Quintanilla et al.,
1986). DMBA (Sigma, 25 mg) in acetone (150 ml) was applied directly to shaved
dorsal skin. After three days, TPA (Sigma, 6.25 mg) was applied in acetone
(150 ml) and repeated twice weekly for 20 weeks or until a carcinoma devel-
oped. Papillomas were counted andmeasured weekly. Final papilloma burden
was calculated by summing the individual products of papilloma number and
the square of each papilloma diameter, which was then normalized across
cohorts against the K14-KD:ER average. Carcinoma conversion rate was
calculated as percentage of carcinomas observed relative to total number of
papillomas.
Histology and Immunohistochemistry
Histology and immunohistochemistry were performed as described (Samuel
et al., 2009b). Antigen retrieval buffer and antibody dilutions used appear in
Supplemental Experimental Procedures. Slides were imaged using a Hama-
matsu Nanozoomer NDP slide scanner (Hamamatsu Photonics) and Digital
Slide Server (Slidepath) software.
Elastic Modulus Measurements and Collagen Staining
The mechanical properties of fresh frozen skin (Foutz et al., 1992) were
assayed using an MFP3D-Bio inverted optical AFM mounted on a Nikon
TE2000-U inverted phase microscope (Asylum Research). Pyramidal Si3N4
cantilevers with a manufacturer spring constant of 0.06N/m fitted with 5 mm
borosilicate glass microspheres (Novascan Tech) were calibrated using the
thermal noise method (Hutter and Bechhoefer, 1993) prior to AFM indentation.
Force maps were acquired by sample indentation with a force of 5 nN. The
Hertz model of impact (Hertz, 1881) was used to calculate the Young’s elastic
modulus of resulting force curves. Heat maps were generated using Igor Pro 6
(Wavemetrics). Picrosirius Red staining was carried out as described (Levental
et al., 2009; Paszek et al., 2005).
Acquisition of Second Harmonic Generation Data from Collagen
Samples of depilated and freshly excised skin were imaged using a 203 0.95
NA water immersion objective on an inverted Nikon TE-2000 microscope
body. The excitation source was a Ti:Sapphire femto-second laser cavity
(Coherent Chameleon Ultra II), coupled into a LaVision Biotec Trim-scope
scan-head. 890 nm excitation wavelength was used to simultaneously collect
SHG signal (435 ± 20 nm) from collagen and autofluorescence (525 ± 25 nm)
from surrounding tissue. Signal was acquired from three separate volumes
measuring 5003 5003 200 mm across each sample, in steps of 2 mm imaging
depth, with an acquisition time of 30 min per volume.
Analysis of SHG Signal from Collagen
ImageJ was used to calculate percentage area covered by SHG signal per
optical slice within a volume, after conversion to a binary image based upon
a manually determined threshold value. Results were expressed as median ±
SEM across all data sets for each genotype. A Grey Level Contrast Matrix
(GLCM) analysis was performed upon optical slices at which maximum
coverage was observed for each phenotype using the USB GLCM plug-in
for ImageJ. The shown parameters were calculated for varying pixel displace-
ment values. Results were expressed as average ± SEM for each parameter for
all genotypes.Statistical Analysis
Unless indicated, statistical significance was determined by Student’s t test.
Data are shown as means ± SD unless indicated. Box and whisker plots
show medians and quartiles with p-values calculated using Mann-Whitney
test for comparing medians. In all cases, p < 0.05 was used as significance
cutoff.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, one table, and threemovies and can be foundwith this article online
at doi:10.1016/j.ccr.2011.05.008.
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